FT News Briefing Thursday, September 12
Sep 12, 2019
Purdue Pharma and the Sackler family are making headlines with a preliminary deal regarding the opioid crisis. Meanwhile, the Pentagon is busy compiling a list of companies linked to the Chinese military. Across the pond, the UK's release of the controversial 'Operation Yellowhammer' document raises eyebrows about a no-deal Brexit. Lastly, investors are wary of Hong Kong Exchanges' massive bid for the London Stock Exchange, sparking debate about competing visions for the future of financial markets.
AI Snips
Chapters
Transcript
Episode notes
Purdue Pharma Settlement
- Purdue Pharma and the Sackler family reached a preliminary deal with several U.S. states and local governments to resolve opioid crisis lawsuits.
- Some states, including New York, refuse to settle, demanding the Sacklers pay more from personal funds.
Pentagon's China List
- The Pentagon is compiling a list of companies linked to the Chinese military, both directly and indirectly.
- This aims to prevent China from acquiring sensitive technologies and protect U.S. defense supply chains.
Operation Yellowhammer Released
- Operation Yellowhammer, the UK's no-deal Brexit plan, reveals potential disruptions like food and fuel shortages.
- France could impose controls, cutting cross-Channel lorry traffic and impacting medicine supplies.